Clinical Trial Update: A Study of Berubicin in Adult Subjects With Recurrent Glioblastoma Multiforme [Phase 2]

View source ↗

Summary

This is an update on a Phase 2 clinical trial evaluating Berubicin in adults with glioblastoma, currently active but not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Glioblastoma

Drugs mentioned

• Berubicin (berubicin)

Snippet

Sponsor: CNS Pharmaceuticals, Inc. | Conditions: Glioblastoma Multiforme, Adult | Phase 2 | Status: ACTIVE_NOT_RECRUITING